Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It’s a hugh deal, and it’s premium over at least 250%! The MMs marked this up over 100% at start made PIs cagey about this. But people will start to realise the enormity of this deal..gla
Buys coning in. Should move towards £1.50+ 100% upside from current price. Will beva good week here
Rns ‘..Consideration Shares valued at approximately US$75.8 million, representing a premium of over 250% to the current market valuation of SalvaRx*..’
This should be at least £1.50 region. RNS is a whopper. Great deal by managemnt
Do not be tempted to sell at this stage.... it is hard to get a true value for the Group.
The demerger of Salvarx Ltd (only part of the Salvrx Group) for the equivalent of 18 Portage shares last seen at US$0.10 gives an equivalent value of £1.41p per SALV share ... and like ly to rise further.
Expect Portage to apply for a London listing in the future to consolidate its prospects for further growth and acquisitions in the Biochem industry.
Its a win, win situation ... sit on your hands and see how it evolves ... especially when US & Canadian markets open.
HUGE DEAL 250% premium plenty of upside
Declan Doogan, CEO of Portage, commented "We are excited about acquiring an additional portfolio of immuno-oncology assets. The SalvaRx team has assembled a diverse group of pharmaceutical products, and has demonstrated success in getting new products into the clinic. We have made an early investment in Stimunity, another Immuno-oncology platform, which is very complementary to SalvaRx's products. With the combined team, we hope to accelerate the timeline to the clinic for these new drugs, and see if we can repeat the success achieved with Biohaven."
Dr. Declan Doogan, M.D., FRCP, has been the Chief Executive Officer at Portage Biotech Inc. since June 4, 2013. Dr. Doogan is a Co-Founder and Managing Director at Juvenescence Limited.
How do you guys feel about that?
Buyers are now returning for SALV. Rather quiet here and I guess some may be missing an opportunity which the recent pull-back created.
SALV is unlikely to stay cheap - a couple of buys at and after the close, with 24p paid, is showing the way.
Quite a gap to make to the where we were only weeks ago.
Cheers blade. Iox always was going to be a slow burner. Intensity is the near-term one which is looking very promising. More details about Intensity on ffwd board.
https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/SALV/13727882.html
Where's the RNS? There doesn't appear to be one.
SalvaRx (LON: SALV), a biotechnology company focused on immunotherapy for cancer, announces that its 57% owned subsidiary, iOx Therapeutics Limited ("iOx"), has experienced a significant delay in manufacturing its lead drug candidate IMM60. Due to quality failures in the manufacturing process that led to a batch failure, iOx is revising its timeline to dosing its first human in clinical trials. The company is confident that its process is robust and that it will move the programme forward in due course. Release of the product required for the initiation of human dosing is now likely to be in late 2019.
I'm very pleased to be well invested with SALV.
It's been a while coming and still the majority are very unaware of this company.
Plenty more to go for here is my main reason for continuing to hild.
After the recent sp crashes in other pharmas due to failed trials, SALV is fast becoming my favorite pharma thanks to the fact it follows a venture capital / investment fund model. Lower risk but still with massive potential rewards. It is to pharma what reabold is to O&G and I'm in both for that reason! Recent rise indicates sthg is afoot but I'm in for the long haul either way, as are the key investors backing the project...
What an amazing week! If the price can move like this without any RNS's, just wait until the newsflow.
Another good rise today. Anyone know what's behind the buying?
Folks need to in to win here, imo.
http://intensitytherapeutics.com/intensity-therapeutics-inc-announces-presentation-int230-6-clinical-study-2018-asco-conference/ All sounds encouraging.
Yes great news. It's a real endorsement of Intensity's future for such a high profile person who was president and COO of Parexel to join the board. That speaks volumes. Salvarx is really under the radar right now but release of clinical data will change all that. If like me Wadders you are in SALV and FFWD it will be a double bonus one day!
On top risers ....
Will soon take my cash all out markets ,is crazy the games this MMS play daily...SO fed up of it just back with money in the bank..